MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-58-0011002
Laniban Pharma Private Limited
Laniban Pharma Private Limited - business services in Roorkee, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹30.66 Lakh
▲ 10% YoY
Net profit · FY 2025
₹4,153
Net margin 0.1%
EBITDA · FY 2025
₹1.38 Lakh
EBITDA margin 4.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Laniban Pharma Private Limited
Data last updated:
Laniban Pharma Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 23 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2018PTC008589. Its GSTIN is 09AADCL5615N1Z4 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Gaurav Kumar and Rajni Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sharif Neardev Bhoomi Industrialarea Nanhera Anantpur, Roorkee, Uttarakhand, India – 247668.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.66 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹4,153 (net margin 0.1%) and EBITDA of ₹1.38 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 20% over five years.
Laniban Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-58-0011002).
Company details
CIN U74999UR2018PTC008589
Registration Number 008589
Incorporation Date 23 March 2018
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-58-0011002
Key People
Gaurav Kumar Director Rajni Tyagi Director Recognitions & Rankings of Laniban Pharma
Contact details
Laniban Pharma Private Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Sharif Neardev Bhoomi Industrialarea Nanhera Anantpur, Roorkee, Uttarakhand, India – 247668
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Laniban Pharma Private Limited, buy the company report.
Comprehensive company report
Laniban Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Laniban Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Laniban Pharma Private Limited, buy the company report.
Financials of Laniban Pharma Private Limited
FY 2025 filings availableLaniban Pharma Private Limited reported revenue of ₹30.66 Lakh (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹30.66 Lakh ▲ 10%
Net profit · FY 2025
₹4,153 margin 0.1%
EBITDA · FY 2025
₹1.38 Lakh margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 7%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 336%
5 years · compounded
▲ 58%
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 10% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,153 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Laniban Pharma Private Limited, buy the company report.
Board of directors of Laniban Pharma Private Limited
Laniban Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Kumar | Director | 23 Mar 2018 | 8 Years 7 Months | Current |
| Rajni Tyagi | Director | 17 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Laniban Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fervid Healthcare Private Limited | ₹30.77 Lakh (FY 2025) | 3.0% | Lucknow, Uttar Pradesh, India | |||
| Allied Polychem Private Limited | ₹30.73 Lakh (FY 2025) | 66.0% | Delhi, India | |||
| Brixy Pharmaceuticals Private Limited | ₹30.72 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Kasiraja Herbal Garden Private Limited | ₹30.71 Lakh (FY 2025) | 34.0% | Tamil Nadu, India | |||
| Pulkit Ayurveda Private Limited | ₹30.7 Lakh (FY 2025) | 68.0% | Chandigarh, India | |||
| Laniban Pharma Private Limitedthis company | ₹30.66 Lakh (FY 2025) | ₹4,153 | 0.1% | 10.0% | Roorkee, Uttarakhand, India | |
| Vrishank Research Private Limited | ₹30.65 Lakh (FY 2025) | -63.0% | Vapi, Gujarat, India | |||
| Gaurav Air Products Private Limited | ₹30.64 Lakh (FY 2024) | -46.0% | Patna, Bihar, India | |||
| Vana Cosmeceutical and Action Research Private Limited | ₹30.62 Lakh (FY 2024) | 19.0% | New Delhi, Delhi, India | |||
| Greno Paints India Private Limited | ₹30.5 Lakh (FY 2024) | -69.0% | Greater Noida, Uttar Pradesh, India | |||
| Bivety Health Care Private Limited | ₹30.48 Lakh (FY 2025) | 249.0% | Hirapur, Jharkhand, India |
To see the full peer comparison of Laniban Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Laniban Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Laniban Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Laniban Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCL5615N1Z4 | Uttar Pradesh | Active | 07 Nov 2019 |
To see the full GST registrations and return filing status of Laniban Pharma Private Limited, buy the company report.
Recent activity
Laniban Pharma Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Rajni Tyagi was appointed as Director on 17 Sep 2019.
AGM
Laniban Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laniban Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Rajni Tyagi was appointed as Director.
Ceased
Vipul Kumar ceased to be Director.
Appointed
Gaurav Kumar was appointed as Director.
Appointed
Vipul Kumar was appointed as Director.
Incorporation
23 Mar 2018
Laniban Pharma Private Limited was registered on 23 Mar 2018 with Roc Uttarakhand & aged 8 years 7 months as per MCA records.
Frequently asked questions
Laniban Pharma is an active private limited company based in Roorkee, Uttarakhand, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 23 March 2018 (8+ years old) and is registered under CIN U74999UR2018PTC008589.
Laniban Pharma has 2 current directors:
- Gaurav Kumar - Director
- Rajni Tyagi - Director
The latest financial statements of Laniban Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Laniban Pharma is 09AADCL5615N1Z4, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Laniban Pharma is U74999UR2018PTC008589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laniban Pharma was incorporated on 23 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Laniban Pharma by revenue are Fervid Healthcare Private Limited, Allied Polychem Private Limited, Brixy Pharmaceuticals Private Limited, Kasiraja Herbal Garden Private Limited, Pulkit Ayurveda Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajni Tyagi was appointed as Director on 17 Sep 2019. Vipul Kumar ceased to be Director on 17 Sep 2019. Gaurav Kumar was appointed as Director on 23 Mar 2018. Laniban Pharma has 4 board changes on record in total.
Yes, Laniban Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-58-0011002).
The registered office of Laniban Pharma is at CO Sharif Neardev Bhoomi Industrialarea Nanhera Anantpur, Roorkee, Uttarakhand, India – 247668.
Laniban Pharma operates in the business services industry, in the miscellaneous business activities segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages